Log In
BCIQ
Print this Print this
 

CTIX-1807

  Manage Alerts
Collapse Summary General Information
Company Cellceutix Corp.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat carbapenem-resistant enterobacteriaceae (CRE) infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today